Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- . (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage ...

SE stock is rated Hold due to valuation constraints and pipeline setbacks, despite strong commercial execution with VYVGART.

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

Ozak AI ($OZ) has emerged as one of the most compelling AI-powered crypto projects combining artificial intelligence with ...

Acrivon Therapeutics, Inc. ('Acrivon” or 'Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company ...

By locking GEE tokens for 12 months, investors can earn an outstanding 55% APR, a significant reward for long-term belief in ...

A new report said the disruption at borders reflects the combination of several operational issues with the deployment of the ...

The Ozak AI is expected to become the highest ROI token of the Year due to its massive presale funding, Advanced AI Technology, which makes the Token unique amo ...

Two private rail operators have publicly expressed interest in operating on the northern Shenandoah Valley’s dormant rail ...